Glycosphingolipid functions: insights from engineered mouse models
about
Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approachesDysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic AgentsSialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regenerationGanglioside Profiling of the Human Retina: Comparison with Other Ocular Structures, Brain and Plasma Reveals Tissue SpecificitiesComplex gangliosides are apically sorted in polarized MDCK cells and internalized by clathrin-independent endocytosis.The roles of glycosphingolipids in the proliferation and neural differentiation of mouse embryonic stem cells.Brain gangliosides in axon-myelin stability and axon regeneration.Neobiosynthesis of glycosphingolipids by plasma membrane-associated glycosyltransferases.Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infectionImino sugar inhibitors for treating the lysosomal glycosphingolipidoses.Biosynthesis and degradation of mammalian glycosphingolipids.Neurobiology and cellular pathogenesis of glycolipid storage diseases.Future perspectives for glycolipid research in medicine.Roles of gangliosides in mouse embryogenesis and embryonic stem cell differentiation.A historical perspective of the glycosphingolipids and sphingolipidoses.Ganglioside biochemistryNeurofibromatosis-like phenotype in Drosophila caused by lack of glucosylceramide extensionBiosynthesis of the major brain gangliosides GD1a and GT1bGangliosides have a functional role during rotavirus cell entry.The way we view cellular (glyco)sphingolipids.Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in GlucosylceramideFunctional roles of gangliosides in neurodevelopment: an overview of recent advances.Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs.Stem cell glycolipids.Roles of sphingolipids in Drosophila development and disease.Metabolic pathways and intracellular trafficking of gangliosides.Sphingolipid lysosomal storage disorders.Trans-activity of plasma membrane-associated ganglioside sialyltransferase in mammalian cells.Cross-linking of glycosphingolipids at the plasma membrane: consequences for intracellular signaling and traffic.Gangliosides of the Vertebrate Nervous SystemEffect of ganglioside GM3 synthase gene knockout on the glycoprotein N-glycan profile of mouse embryonic fibroblast.Disease-modifying effects of ganglioside GM1 in Huntington's disease models.Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers
P2860
Q21129299-FC389DC1-644F-4BFC-9DD6-93913F51A63AQ26771367-F9CDCBBF-8367-4D95-8523-114BD1A433CFQ26995291-76150F47-7334-4FC5-BF25-C0804E8B1F0CQ28555147-03F03C3A-A222-42E9-8EF5-A4E879E92AA0Q33385837-97120246-EF92-4F29-AD6F-D4D474BCA687Q33575797-79679D6F-FD41-4CFA-9ABC-D81466925E6BQ33798789-86CBCA23-B937-4BE8-AFDA-9DCE2D33038CQ34121503-C65A2C43-FE78-433A-A9D8-5F5F993E3F01Q34186010-7BF5F20D-E1EC-495A-A1ED-73970555D7B1Q34557737-DDA00277-7076-480D-9CFA-D87F1A05EEC5Q35153204-49132E0B-5C9F-4876-9DB4-FFBD062F279BQ35153227-E8038F8E-D7D7-47F4-8F45-C30B62131F39Q35153243-5A716A0D-0CBB-4F07-B57E-80D66E1ED89EQ35171847-4A0B074E-F576-4D0F-8A18-03852FA491D4Q35213537-E823E3A8-ADCA-4CAC-9E4F-DDA9F15BB22AQ35361488-50F12B1C-FF81-4E75-97B9-F93D882142FEQ35935658-1051CE5A-9DBA-44A5-A593-AF596A7D65CBQ36182168-0EC30C52-79C8-4773-9A5F-EB584F1E8B05Q36559541-FD0AA1BD-9BC9-4FF8-8E7E-4524301DD50FQ36994532-E782967F-7CA9-4715-9CDC-DFDB88B013FCQ37377548-06DEDF08-134F-45D3-A5AE-8B805FEDB02CQ37494316-9EE4750B-213F-4038-B733-984819D3C4C9Q37549241-87C7D9B6-718F-42C8-B321-041CD9419111Q37821360-7BD2FEDB-71F4-4496-BD7B-CCB20B633843Q37826774-BE28A775-E5E8-4C4E-981F-2EEB5FEFD872Q37893592-8A725A60-B582-4DAE-B18B-29B82E88ABF1Q38217766-B234E07C-1ACB-45F6-B587-4B438BD10271Q38419747-E38B198C-CC7E-41FA-8315-D18B096AAE73Q38832453-EF0FA842-64C7-4DD1-8069-CAA2FA00C4C7Q38853822-4ADBFBE7-A790-4C60-AF9B-CEB78E95B9F8Q39229360-F9EE1DA1-993E-4C4D-92F2-543B8AAF9D1DQ47154575-E058DBE8-4118-46C1-963E-8259915EDFFBQ50092191-09C4E7D8-D100-4EAD-9267-6D9477B952E1Q57274173-EA4AA3E2-57B8-413F-8743-643559D63FC0
P2860
Glycosphingolipid functions: insights from engineered mouse models
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Glycosphingolipid functions: insights from engineered mouse models
@ast
Glycosphingolipid functions: insights from engineered mouse models
@en
type
label
Glycosphingolipid functions: insights from engineered mouse models
@ast
Glycosphingolipid functions: insights from engineered mouse models
@en
prefLabel
Glycosphingolipid functions: insights from engineered mouse models
@ast
Glycosphingolipid functions: insights from engineered mouse models
@en
P2860
P356
P1476
Glycosphingolipid functions: insights from engineered mouse models
@en
P2093
Richard L Proia
P2860
P304
P356
10.1098/RSTB.2003.1268
P407
P577
2003-05-01T00:00:00Z